ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

November 6, 1981

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985